GrowingStockReport.com

Aixtron SE (NASDAQ:AIXG) and ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 03/25/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Aixtron SE (NASDAQ:AIXG) and ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP).

Aixtron SE (NASDAQ:AIXG) a company that together with its subsidiaries, engages in developing, producing, and installing deposition equipment for the semiconductor and compound-semiconductor industry is currently up (+6.74%) on 348,828 shares traded after Aixtron was upgraded to Hold from Sell at Canaccord. Aixtron SE (NASDAQ:AIXG) is currently up (+32.38%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Aixtron SE (NASDAQ:AIXG)

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) a biopharmaceutical company that focuses on the development and commercialization of new cancer therapies is currently up (+5.34%) on 1,593,900 shares traded after ZIOPHARM ONCOLOGY INC Reported its Financials. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) is currently up (+52.98%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com